Last edition
News about Global Pharma
Poseida Therapeutics Welcomes Syed Rizvi as New Chief Medical Officer
Poseida Therapeutics, Inc. has appointed Syed Rizvi, MD, as Chief Medical Officer effective April 1, 2024.
<br />
Global Pharma | 26/03/2024 | By Manvi | 962
Scivita Medical Signs Extended Partnership with Boston Scientific
Scivita Medical Technology Co., Ltd. has signed an expanded strategic cooperation arrangement with Boston Scientific.
Global Pharma | 26/03/2024 | By Manvi | 592
Astellas Pharma Inc. announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of XTANDI™ (enzalutamide) as monotherapy.
Global Pharma | 22/03/2024 | By Manvi | 426
FDA Grants Approval to PPMD DUVYZAT for Duchenne Patients
Parent Project Muscular Dystrophy has been granted approval of DUVYZAT (givinostat) a histone deacetylase (HDAC) inhibitor indicated for individuals diagnosed with Duchenne six years of age and older by FDA.
Global Pharma | 22/03/2024 | By Manvi | 741
The acquisition is poised to enhance Lonza's large-scale biologics manufacturing capacity, catering to the growing demand for commercial mammalian contract manufacturing.
Global Pharma | 22/03/2024 | By Abha | 1231
Tonix Pharmaceuticals Secures Dual Manufacturing Partners for Potential Tonmya Launch
The biopharmaceutical company has selected two contract manufacturing organizations (CMOs), with one being Almac Pharma Services, a member of the Almac Group, as dual supply sources for Tonmya™.
Global Pharma | 22/03/2024 | By Abha | 1396
Samsung Accepts Healthcare Innovator Award for Contribution to Care in Underserved Communities
Boston Imaging was awarded HHM Health’s Healthcare Innovator Award for its SonoSync technology and contributions to closing the gap in quality, accessible healthcare for underserved communities.
Global Pharma | 21/03/2024 | By Manvi | 500
Babson Diagnostics to Launch Transformative Blood Testing Service with Leading Retail Partners
Babson Diagnostics announced that it will launch BetterWay™ blood testing with three retail partners in Austin and San Antonio.
Global Pharma | 21/03/2024 | By Manvi | 279
Phanes Therapeutics Earns FDA Fast Track Status for Pancreatic Adenocarcinoma Treatment
Phanes Therapeutics has announced that the US Food and Drug Administration has granted Fast Track designation to PT886 for the treatment of patients with metastatic claudin 18.2-positive pancreatic adenocarcinoma.
Global Pharma | 21/03/2024 | By Manvi | 1048
Roquette to Acquire IFF Pharma Solutions, Strengthening Position in Pharmaceutical Industry
The merger of Roquette and IFF Pharma Solutions will serve to rebalance Roquette's portfolio around the pillars of Health and Nutrition, expanding its pharma product range and accelerating its growth course.
Global Pharma | 21/03/2024 | By Abha | 600
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy